ASSURE Wearable ECG vs Tempus ECG-Low EF
AI Verdict
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you need continuous, long-term heart rate monitoring and remote patient data collection for at-risk cardiac patients. This tool is ideal for ongoing management, providing alert-based notifications and physiologic trend data to clinicians for proactive intervention and comprehensive oversight outside of a clinical setting.
View ASSURE Wearable ECG →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you require an AI-powered diagnostic aid to screen for signs associated with low left ventricular ejection fraction (LVEF ≤40%) from a standard 12-lead ECG in a clinical facility. This software is best suited for quickly identifying patients 40 years or older at risk of heart failure during a clinical visit, providing a binary output to guide further evaluation.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | Tempus ECG-Low EF |
|---|---|---|
| Deployment | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. | Integrates with current ECG platforms and electronic health records (EHRs). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGTool A, the ASSURE Wearable ECG, offers a patient-centric experience with a wearable device, mobile application, and cloud platform, promoting continuous monitoring and remote care. Its SensorFit Garment emphasizes ease of use and comfort for patients. While Tool B integrates into existing clinical workflows, Tool A's multi-faceted approach provides broader usability for both patients and providers in a remote setting.
Clinical Value
Tempus ECG-Low EFTool B, Tempus ECG-Low EF, provides a specific, FDA-cleared diagnostic aid for detecting signs of low LVEF from a single 12-lead ECG, which has a high impact on identifying patients at risk for heart failure. This offers direct clinical decision support based on a large training dataset. Tool A provides continuous monitoring and trend data, valuable for long-term management, but its immediate diagnostic impact is less specific than Tool B's targeted LVEF detection.
Pricing & Value
TieBoth tools require direct contact for pricing, making it impossible to conduct a transparent head-to-head comparison of their costs. Without specific pricing details, it is not feasible to definitively determine which tool offers superior value for its features and clinical benefits.
Enterprise Readiness
Tempus ECG-Low EFBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. However, Tool B's deployment as 'Software, integrated into healthcare facility workflows' suggests a potentially simpler and more streamlined integration into existing IT infrastructure. Tool A's multi-component system (wearable, mobile app, cloud platform) might require more extensive deployment and management strategies for a healthcare enterprise.
Innovation
TieTool A showcases innovation through its wearable form factor, SensorFit Garment technology for comfortable continuous monitoring, and advanced signal processing for artifact reduction. Tool B demonstrates innovation by applying AI to standard 12-lead ECGs to predict a specific, critical cardiac condition (low LVEF) using a massive training dataset. Both represent significant advancements in their respective areas of cardiac care.
Support & Docs
ASSURE Wearable ECGKestra Medical Technologies explicitly highlights a 24/7 ASSURE Helpline and provides patient-specific documentation like a Patient Handbook and User Manual for the ASSURE system. Tempus AI offers general contact methods and a resource center, but Kestra's clear emphasis on a dedicated, round-the-clock helpline for their specific product indicates a more robust and readily accessible support structure for users of the ASSURE Wearable ECG.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | Tempus ECG-Low EF |
|---|---|---|
| Name | ASSURE Wearable ECG | Tempus ECG-Low EF |
| Company | Kestra Medical Technologies | Tempus AI |
| Primary Function | Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients. | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. |
| Key Technology/Algorithm | ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts. | AI-powered algorithm for ECG analysis, trained on a large dataset of over 930,000 ECGs from 170,000+ patients. |
| Target Condition/Detection | Continuous heart rate monitoring, automatic episode storage, physiologic trend data. | Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%). |
| Data Input/Analysis Type | Continuous ECG from wearable device (SensorFit Garment). | Resting, non-ambulatory 12-lead ECG recordings. |
| Target Patient Population | At-risk cardiac patients. | Patients 40+ years at risk of heart failure. |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring ASSURE Wearable ECG or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.